This guide walks through a complete integration step by step, using the 2328 crypto payment API as the example. The ...

Google’s newest Gemini model could help do them for you. To support Argon’s complex workflows, Google is expanding the ...

No sign-up, no watermark and no cost: freelancers and small businesses can create and download a professional PDF invoice in under a minute.New York, New York--(Newsfile Corp. - October 1, 2026) - ...

SAN FRANCISCO, Sept. 15, 2026 /PRNewswire/ -- Generate Capital ("Generate"), a leading investor, owner and operator of critical infrastructure, today announced the closing of a $117 million term debt ...

Phase 1 data from Generate Biomedicines’ ongoing chronic obstructive pulmonary disease study demonstrated “rapid and sustained reductions” across four disease biomarkers. AI-driven Generate ...

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness. Unpaid invoices can create serious problems for a ...

Tern has also released further capabilities to reduce manual work surrounding advisor payouts, service fees and membership dues. Photo Credit: smx12/Shutterstock Tern has expanded its back-office ...

We've tested the top AI image generation apps to help you find the one that produces the best results for the lowest price. I’ve been writing about consumer technology and video games for more than a ...

AI has taken the world by storm over the last few years, with millions of users writing prompts on platforms like ChatGPT to generate content, images, and yes videos. Still, some of these platforms ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines has earmarked $300 million of its IPO funds to complete a pair of phase 3 asthma trials for its anti-TSLP antibody GB-0895. (Fabrice Cabaud/Stock/Getty Images Plus) ...